Effects of probiotics/synbiotic interventions on cognitive dysfunction in Alzheimer's or MCI: A systematic review and meta‑analysis of randomized controlled trials
Ageing Research Reviews · 2027-01 · 123 · 103442
DOI: 10.1016/j.arr.2026.103442 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2027-01. Verfasst von Mengyu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Child and Adolescent Health, School of Public Health, Hangzhou Medical College, Hangzhou 310014, PR China. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
OBJECTIVE: To systematically evaluate the effects of probiotics or synbiotics on cognitive function in individuals with mild cognitive impairment, Alzheimer's disease, and related cognitive decline. METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to 20 September 2026. Randomized controlled trials comparing viable probiotics or synbiotics with placebo or usual care were included. Cognitive changes were pooled as standardized mean differences (SMDs) using a random-effects model. Subgroup, sensitivity, RoB 2, Egger, and GRADE assessments were conducted. RESULTS: Ten trials involving 739 participants were included. Probiotics or synbiotics were associated with a possible improvement in cognitive function (SMD = 0.50, 95% CI: 0.19, 0.81; P = 0.002; Ι2 = 76%). The approximate 95% prediction interval was -0.57-1.57. No statistically significant differences in treatment effects were detected between subgroups defined by disease category, intervention duration, intervention type, study-level mean age, strain composition, dosage, or cognitive instrument. The effect was numerically larger in studies with a mean age ≤ 70 years, but this difference was not significant (P = 0.17) and was sensitive to individual studies. Sensitivity analyses maintained the direction and statistical significance of the pooled effect. Egger's test showed no significant small-study effects (Z = 1.00, P = 0.318). The certainty of evidence was very low. CONCLUSION: Probiotics or synbiotics may improve cognitive test performance, but the certainty of evidence is very low because of risk of bias, substantial heterogeneity, and imprecision. Exploratory subgroup analyses did not provide clear evidence that disease category, intervention duration, intervention type, study-level mean age, strain composition, dosage, or cognitive assessment instrument modified the treatment effect. Larger, well-designed randomized trials are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition, Child and Adolescent Health, School of Public Health, Hangzhou Medical College, Hangzhou 310014, PR China.
- Department of Nutrition, Child and Adolescent Health, School of Public Health, Hangzhou Medical College, Hangzhou 310014, PR China. Electronic address: withxu@hmc.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M., Zhang, H., Fu, B., & Xu, D. (2027). Effects of probiotics/synbiotic interventions on cognitive dysfunction in Alzheimer's or MCI: A systematic review and meta‑analysis of randomized controlled trials. Ageing Research Reviews, 123, 103442. https://doi.org/10.1016/j.arr.2026.103442
Vancouver
Zhang M, Zhang H, Fu B, Xu D. Effects of probiotics/synbiotic interventions on cognitive dysfunction in Alzheimer's or MCI: A systematic review and meta‑analysis of randomized controlled trials. Ageing Research Reviews. 2027;123:103442. doi:10.1016/j.arr.2026.103442
BibTeX
@article{Zhang2027,
author = {Zhang, Mengyu and Zhang, Haoyue and Fu, Bingmeng and Xu, Dengfeng},
title = {Effects of probiotics/synbiotic interventions on cognitive dysfunction in Alzheimer's or MCI: A systematic review and meta‑analysis of randomized controlled trials},
journal = {Ageing Research Reviews},
year = {2027},
volume = {123},
pages = {103442},
doi = {10.1016/j.arr.2026.103442}
}
EUVIMED